S-8 POS 1 g083909_s8pos.htm S-8 POS

 

 As filed with the Securities and Exchange Commission on January 3, 2024

Registration No. 333-89680

 

UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Post-Effective Amendment No. 1

to

FORM S-8

 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

CITIZENS HOLDING COMPANY

 (Exact name of Registrant as specified in its charter)

 

Mississippi   64-0666512
(State or other jurisdiction of incorporation or organization)  

(I.R.S. Employer Identification Number)

 

521 Main Street

 Philadelphia, MS 39350

(601) 656-4692

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

1999 Directors’ Stock Compensation Plan

 and

1999 Employees’ Long-Term Incentive Plan

(Full title of the plan)

 

Stacy M. Brantley

Chairman and Chief Executive Officer

521 Main Street

Philadelphia, MS 39350

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

With a copy to:

Nathanael P. Kibler

Baker, Donelson, Bearman, Caldwell & Berkowitz, PC

265 Brookview Centre Way, Suite 600

 Knoxville, TN 37919

 (865) 549-7000

 (865) 525-8569 (fax)

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐     Accelerated filer ☐  
Non-accelerated filer ☒     Smaller reporting company ☒  
      Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.

 

 

 

This Registration Statement shall become effective upon filing in accordance with Rule 464 promulgated under the Securities Act of 1933, as amended.

 

 

 

 

DEREGISTRATION OF SECURITIES

 

Citizens Holding Company (the “Company”) is a bank holding company, and the class of securities to which this Registration Statement on Form S-8 (File No. 333-89680) (the “Registration Statement”) relates is held by fewer than 1,200 shareholders of record. The Company is filing this Post-Effective Amendment No. 1 to the Registration Statement to deregister all of the shares of common stock, $0.20 par value, of the Company, and related stock options therefor, registered under the Registration Statement that remain unissued under the 1999 Directors’ Stock Compensation Plan and the 1999 Employees’ Long-Term Incentive Plan.

 

2 

 

 

SIGNATURES

 

The Registrant. Pursuant to the requirements of the Securities Exchange Act of 1933, as amended, the Registrant certifies that is has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this post-effective amendment to the registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Philadelphia, State of Mississippi, on January 3, 2024.

 

    CITIZENS HOLDING COMPANY
       
    By: /s/ Stacy M. Brantley
    Stacy M. Brantley 
      President and Chief Executive Officer

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date indicated.

 

Signature Title(s) Date
     
/s/ Stacy M. Brantley President and  
Stacy M. Brantley Chief Executive January 3, 2024
  Officer and Director  
  (Principal Executive Officer)  
     
  Treasurer and  
/s/ Phillip R. Branch Chief Financial Officer January 3, 2024
Phillip R. Branch (Principal Financial Officer and  
  Chief Accounting Officer)  
     
     
/s/ Gregory E. Cronin Director January 3, 2024
Gregory E. Cronin    
     
/s/ Donald L. Kilgore Director January 3, 2024
Donald L. Kilgore    
     
/s/ Herbert A. King Director January 3, 2024
Herbert A. King    
     
/s/ Jason R. Voyles Director January 3, 2024
Jason R. Voyles    
     
/s/ David A. King Director January 3, 2024
David A. King
     
/s/ Greg L. McKee Director January 3, 2024
Greg L. McKee    
     
/s/ Terrell E. Winstead Director January 3, 2024
Terrell E. Winstead    

 

3 

 

 

/s/ Jane D. Crosswhite Director January 3, 2024
Jane D. Crosswhite    
     
/s/ Craig Dungan, MD Director January 3, 2024
Craig Dungan, MD    
     
/s/ Daniel Adam Mars Director January 3, 2024
Daniel Adam Mars    
     
/s/ David P. Webb Director January 3, 2024
David P. Webb    

 

 

4